Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Relevium Technologies Inc V.RLV.H

Alternate Symbol(s):  RLLVF

Relevium Technologies Inc. is a Canada-based company, which operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets with a focus on e-commerce. The Company operates through two wholly owned subsidiaries, BGX E-Health LLC and Biocannabix Health Corporation Inc. BGX E-Health LLC markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals, primarily through its Bioganix brand portfolio online in the United States. It provides a Push & Pull System by Bioganix. Push & Pull System is a comprehensive natural anti-aging system for complete skin care that combines collagen protein supplements (PUSH) and naturally sourced aloe vera skin anti-aging cream (PULL).


TSXV:RLV.H - Post by User

Bullboard Posts
Post by fruiscante1on Mar 16, 2017 12:37pm
124 Views
Post# 25988623

a few takeaways from the CEO presentation

a few takeaways from the CEO presentation The $1.7 EBITDA is essentially net cashflow, as there is not interest, debt, etc

Figiure they can do $20M in revenues with only full time employees.

Next aquisiton may be in the next few months.

Able to buy companies at 2-4 X EBITDA, and realize valuations of 6-10 X EBITA in the public market.

Looking at CBD (cannabis) market, in discussions with several parties).New board member appointment announced soon.


Bullboard Posts